Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Meta-immunological profiling of children with type 1 diabetes identifies new biomarkers to monitor disease progression.

Galgani M, Nugnes R, Bruzzese D, Perna F, De Rosa V, Procaccini C, Mozzillo E, Cilio CM, Elding Larsson H, Lernmark A, La Cava A, Franzese A, Matarese G.

Diabetes. 2013 Jul;62(7):2481-91. doi: 10.2337/db12-1273. Epub 2013 Feb 8.

2.

Neuronal T-cell autoreactivity is amplified in overweight children with new-onset insulin-requiring diabetes.

Buryk MA, Dosch HM, Libman I, Arena VC, Huang Y, Cheung RK, Trucco M, Pietropaolo M, Becker DJ.

Diabetes Care. 2015 Jan;38(1):43-50. doi: 10.2337/dc14-1861. Epub 2014 Nov 20.

3.

Islet-specific T-cell responses and proinflammatory monocytes define subtypes of autoantibody-negative ketosis-prone diabetes.

Brooks-Worrell BM, Iyer D, Coraza I, Hampe CS, Nalini R, Ozer K, Narla R, Palmer JP, Balasubramanyam A.

Diabetes Care. 2013 Dec;36(12):4098-103. doi: 10.2337/dc12-2328. Epub 2013 Oct 15.

4.

Insulin and type 1 diabetes: immune connections.

Culina S, Brezar V, Mallone R.

Eur J Endocrinol. 2013 Jan 17;168(2):R19-31. doi: 10.1530/EJE-12-0693. Print 2013 Feb. Review.

5.

Islet autoimmunity identifies a unique pattern of impaired pancreatic beta-cell function, markedly reduced pancreatic beta cell mass and insulin resistance in clinically diagnosed type 2 diabetes.

Subauste A, Gianani R, Chang AM, Plunkett C, Pietropaolo SL, Zhang YJ, Barinas-Mitchell E, Kuller LH, Galecki A, Halter JB, Pietropaolo M.

PLoS One. 2014 Sep 16;9(9):e106537. doi: 10.1371/journal.pone.0106537. eCollection 2014.

6.

The multiple origins of Type 1 diabetes.

Pugliese A.

Diabet Med. 2013 Feb;30(2):135-46. doi: 10.1111/dme.12081. Review.

PMID:
23181718
7.

Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young children.

Ziegler AG, Pflueger M, Winkler C, Achenbach P, Akolkar B, Krischer JP, Bonifacio E.

J Autoimmun. 2011 Aug;37(1):3-7. doi: 10.1016/j.jaut.2011.02.004. Epub 2011 Mar 3.

8.

Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex capture.

Allen JS, Pang K, Skowera A, Ellis R, Rackham C, Lozanoska-Ochser B, Tree T, Leslie RD, Tremble JM, Dayan CM, Peakman M.

Diabetes. 2009 Jan;58(1):138-45. doi: 10.2337/db08-0964. Epub 2008 Oct 3.

9.

Insulin secretion and sensitivity in the prediction of type 1 diabetes in children with advanced β-cell autoimmunity.

Siljander HT, Hermann R, Hekkala A, Lähde J, Tanner L, Keskinen P, Ilonen J, Simell O, Veijola R, Knip M.

Eur J Endocrinol. 2013 Sep 14;169(4):479-85. doi: 10.1530/EJE-13-0206. Print 2013 Oct.

10.

Autoimmune responses in T1DM: quantitative methods to understand onset, progression, and prevention of disease.

Jaberi-Douraki M, Liu SW, Pietropaolo M, Khadra A.

Pediatr Diabetes. 2014 May;15(3):162-74. doi: 10.1111/pedi.12148. Review.

11.

Humoral autoimmunity in type 1 diabetes: prediction, significance, and detection of distinct disease subtypes.

Pietropaolo M, Towns R, Eisenbarth GS.

Cold Spring Harb Perspect Med. 2012 Oct 1;2(10). pii: a012831. doi: 10.1101/cshperspect.a012831. Review.

12.

Effects of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetes.

Sherry NA, Kushner JA, Glandt M, Kitamura T, Brillantes AM, Herold KC.

Diabetes. 2006 Dec;55(12):3238-45.

13.

Th1/Th17 plasticity is a marker of advanced β cell autoimmunity and impaired glucose tolerance in humans.

Reinert-Hartwall L, Honkanen J, Salo HM, Nieminen JK, Luopajärvi K, Härkönen T, Veijola R, Simell O, Ilonen J, Peet A, Tillmann V, Knip M, Vaarala O; DIABIMMUNE Study Group; DIABIMMUNE Study Group.

J Immunol. 2015 Jan 1;194(1):68-75. doi: 10.4049/jimmunol.1401653. Epub 2014 Dec 5.

14.

Contrasting cellular and humoral autoimmunity associated with latent autoimmune diabetes in adults.

Mayer A, Fabien N, Gutowski MC, Dubois V, Gebuhrer L, Bienvenu J, Orgiazzi J, Madec AM.

Eur J Endocrinol. 2007 Jul;157(1):53-61.

15.

Beyond the hormone: insulin as an autoimmune target in type 1 diabetes.

Brezar V, Carel JC, Boitard C, Mallone R.

Endocr Rev. 2011 Oct;32(5):623-69. doi: 10.1210/er.2011-0010. Epub 2011 Jun 23. Review.

PMID:
21700723
16.

Immunologic and metabolic biomarkers of β-cell destruction in the diagnosis of type 1 diabetes.

Lebastchi J, Herold KC.

Cold Spring Harb Perspect Med. 2012 Jun;2(6):a007708. doi: 10.1101/cshperspect.a007708. Review.

17.

The case for an autoimmune aetiology of type 1 diabetes.

Mannering SI, Pathiraja V, Kay TW.

Clin Exp Immunol. 2016 Jan;183(1):8-15. doi: 10.1111/cei.12699. Epub 2015 Oct 21. Review.

18.

Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth.

Skyler JS, Pugliese A.

Diabetes Technol Ther. 2013 Jun;15 Suppl 2:S2-13-S2-20. doi: 10.1089/dia.2013.0107.

19.

Tumor necrosis factor-related apoptosis-inducing ligand and CD56 expression in patients with type 1 diabetes mellitus.

Cheung SS, Metzger DL, Wang X, Huang J, Tai J, Tingle AJ, Ou D.

Pancreas. 2005 Mar;30(2):105-14.

PMID:
15714132
20.

Beta cell function and ongoing autoimmunity in long-standing, childhood onset type 1 diabetes.

Williams GM, Long AE, Wilson IV, Aitken RJ, Wyatt RC, McDonald TJ, Wong FS, Hattersley AT, Williams AJ, Bingley PJ, Gillespie KM.

Diabetologia. 2016 Dec;59(12):2722-2726. Epub 2016 Sep 3.

PMID:
27591853

Supplemental Content

Support Center